Elanco Animal Health Incorporated Common Stock (ELAN)
Stock · NYSE · Health Care
$23.56as of 10/16/2026
Price chart
Active signals
ELAN Signal Track Record
How signals performed across all stocks →What ELAN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | -1.4% | 42% | September 10, 2026 |
| Bollinger Band BreakoutActive now | 24 | +1.5% | 54% | July 29, 2026 |
| Bollinger Band Breakdown | 21 | -2.2% | 48% | August 6, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -2.2% | 36% | September 9, 2026 |
| Any 20-session window (baseline) | +0.4% | 52% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 9,400
- Website
- www.elanco.com/
Fundamentals
- 1-day range
- $22.8$23.79
- Market cap
- $12.09B
- P/E (trailing)
- —
- P/E (forward)
- 18.32
- EPS (trailing)
- $-0.42
- Dividend yield
- —
- Beta
- 1.75
- Avg. volume
- 6.18M
How Elanco Animal Health Incorporated Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
13 analyst ratings
Elanco Animal Health Incorporated Common Stock Competitors
Chosen by industry and closest market cap.
- ELANElanco Animal Health Incorporated Common Stock$23.55▲ 0.04%Market cap $12.09BP/E —$19.4$27.98
- ARWRArrowhead Pharmaceuticals Inc. Common Stock$55.9▼ 4.44%Market cap $12.12BP/E —$36.02$95.49
- BMRNBioMarin Pharmaceutical Inc. Common Stock$54.68▼ 2.44%Market cap $11.88BP/E 151.14$49.26$70.98
- MDGLMadrigal Pharmaceuticals Inc. Common Stock$449.74▼ 2.19%Market cap $11.79BP/E —$393.61$615
- CORTCorcept Therapeutics Incorporated Common Stock$110.16▼ 2.83%Market cap $11.67BP/E 225.11$28.66$126.38
- ABVXAbivax SA American Depositary Shares$88.13▼ 4.60%Market cap $11.19BP/E —$60.45$139
- AXSMAxsome Therapeutics Inc. Common Stock$157.14▼ 2.87%Market cap $10.81BP/E —$120.12$260.19
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ELAN Elanco Animal Health Incorporated Common Stock | $12.09B | — | $23.55 | ▲ 0.04% | $19.4$27.98 |
| ARWR Arrowhead Pharmaceuticals Inc. Common Stock | $12.12B | — | $55.9 | ▼ 4.44% | $36.02$95.49 |
| BMRN BioMarin Pharmaceutical Inc. Common Stock | $11.88B | 151.14 | $54.68 | ▼ 2.44% | $49.26$70.98 |
| MDGL Madrigal Pharmaceuticals Inc. Common Stock | $11.79B | — | $449.74 | ▼ 2.19% | $393.61$615 |
| CORT Corcept Therapeutics Incorporated Common Stock | $11.67B | 225.11 | $110.16 | ▼ 2.83% | $28.66$126.38 |
| ABVX Abivax SA American Depositary Shares | $11.19B | — | $88.13 | ▼ 4.60% | $60.45$139 |
| AXSM Axsome Therapeutics Inc. Common Stock | $10.81B | — | $157.14 | ▼ 2.87% | $120.12$260.19 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- This Urban Outfitters Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga · 10/16/2026
- 1 Healthcare Stock Worth Your Attention and 2 We Turn DownYahoo · 10/9/2026
- Elanco Animal Health Reports Q2 2026 Results: Full Earnings Call TranscriptBenzinga · 10/8/2026
- One Health Innovation District Breaks Ground on One Health Research Institute, Anchored by Purdue University and Elanco Animal HealthYahoo · 10/7/2026
- 2 Cash-Producing Stocks for Long-Term Investors and 1 Facing HeadwindsYahoo · 10/6/2026
- 1 Mid-Cap Stock to Keep an Eye On and 2 We IgnoreYahoo · 10/5/2026
- Elanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain GroundYahoo · 9/26/2026
- Elanco Animal Health Incorporated (ELAN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeekingAlpha · 9/22/2026
- Elanco to Participate in BofA Securities Global Healthcare Conference 2026Yahoo · 9/17/2026
Insider Activity
Insider Actions →- Rajeev A. Modi · October 2, 2026 · Grant67 @ $22.14
- Robert M. VanHimbergen · October 2, 2026 · Grant9 @ $22.14
- Jeffrey N. Simmons · October 2, 2026 · Grant128 @ $22.14
- Kapila K. Anand · September 30, 2026 · Grant642 @ $22.39
- Rajeev A. Modi · September 18, 2026 · Grant66 @ $22.42
- Robert M. VanHimbergen · September 18, 2026 · Grant9 @ $22.42
- Jeffrey N. Simmons · September 18, 2026 · Grant126 @ $22.42
- Rajeev A. Modi · September 4, 2026 · Grant60 @ $24.5
- Robert M. VanHimbergen · September 4, 2026 · Grant8 @ $24.5
- Jeffrey N. Simmons · September 4, 2026 · Grant115 @ $24.5
- Robert M. VanHimbergen · August 21, 2026 · Grant8 @ $23.97
- Rajeev A. Modi · August 21, 2026 · Grant62 @ $23.97
- Jeffrey N. Simmons · August 21, 2026 · Grant118 @ $23.97
- Lawrence Erik Kurzius · August 20, 2026 · Buy40.0K @ $23.4
- O'Neill Shiv · August 18, 2026 · Buy4.0K @ $23.58
Institutional Ownership
March 31, 2026
- Total shares held
- 516.87M
- Total value held
- $11.36B
- Institutional holders
- 504
- Unknown68.94M
- Unknown50.93M
- Unknown47.62M
- Unknown45.84M
- Unknown34.64M
- Unknown24.53M
- Unknown22.34M
- Unknown15.34M
- Unknown13.61M
- Unknown11.19M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Elanco (ELAN) Highlighted in Mid-Cap Stock Watchlist
Elanco was included in a recent Yahoo Finance article listing mid-cap stocks to monitor. The company is currently trading near its 52-week low, with an RSI of 38.5 indicating potential oversold conditions. Analysts maintain an average price target of $31.00, which is higher than the current trading level.
Elanco (ELAN) Highlighted in Mid-Cap Stock Watchlist. Elanco was included in a recent Yahoo Finance article listing mid-cap stocks to monitor. The company is currently trading near its 52-week low, with an RSI of 38.5 indicating potential oversold conditions. Analysts maintain an average price target of $31.00, which is higher than the current trading level.